This inventor holds 1 USPTO granted patent. Top assignee: Aktis Oncology, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Marci Lynn Copeland: Innovator in Oncology
Introduction
Marci Lynn Copeland is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of oncology through her innovative work. With a focus on developing new therapeutic approaches, her research has the potential to impact cancer treatment significantly.
Latest Patents
Marci holds a patent for "B7-H3 Miniproteins, Conjugates, and Uses Thereof." This patent represents her commitment to advancing cancer therapies and showcases her expertise in the field.
Career Highlights
Marci is currently employed at Aktis Oncology, Inc., where she continues to push the boundaries of cancer research. Her work at the company emphasizes the importance of innovation in developing effective treatments for patients.
Collaborations
Throughout her career, Marci has collaborated with notable colleagues, including Michael Lawrence Doligalski and Andrew Clay. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Marci Lynn Copeland is a dedicated inventor whose work in oncology is paving the way for new therapeutic options. Her contributions, particularly through her patent and collaborations, highlight her role as a key figure in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile